Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer

Summary

This study aims to evaluate patients with metastatic castrate-resistant prostate cancer (mCRPC) undergoing treatment with sipuleucel-T for evidence of treatment-associated immune activation in lymph nodes and peripheral blood.

Timeline

Start

2014-03

Primary completion

2019-02-06

Completion

2019-02-06

Drugs

Indications